SMTL ID : 5hvy.1

CDK8/CYCC IN COMPLEX WITH COMPOUND 20

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 66X: N-{(3S)-1-[2-(methylamino)pyrimidin-4-yl]pyrrolidin-3-yl}-N'-{4-[(morpholin-4-yl)methyl]-3-(trifluoromethyl)phenyl}urea(Non-covalent)

66X.1: 26 residues within 4Å: Chain A: V.30, V.38, A.53, K.55, R.68, E.69, L.72, L.73, L.76, V.81, I.82, F.100, D.101, Y.102, A.103, L.145, V.150, L.151, H.152, R.153, L.161, I.174, A.175, D.176, M.177, R.359 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:K.55, A:E.69, A:L.73, A:L.73, A:I.82, A:I.82, A:F.100, A:L.161, A:D.176 Hydrogen bonds: A:A.103, A:A.103, A:D.176, A:R.359 Salt bridges: A:E.69 Halogen bonds: A:I.174

1 x FMT: FORMIC ACID(Non-functional Binders)

FMT.2: 6 residues within 4Å: Chain A: E.20, F.23, E.24, Y.25, E.26, K.44 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.20, A:Y.25, A:E.26

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 4 residues within 4Å: Chain B: Y.41, Q.45, F.73, Y.77 Ligand excluded by PLIP CL.4: 5 residues within 4Å: Chain B: K.3, A.4, M.5, A.6, I.155 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bergeron, P. et al., Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8. Acs Med.Chem.Lett. (2016)

Release Date

2016-04-20

Peptides

Cyclin-dependent kinase 8: A
Cyclin-C: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 8

Cyclin-C

Related Entries With Identical Sequence